Discover 901 paid clinical trials in Birmingham, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 901
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
for
Sickle Cell Disease (SCD)
Location: Birmingham AL, Atlanta GA, Memphis TN, Charlotte NC,
Sponsor: University of Rochester
Sex: All
Age: 3 - 20
Code: NCT06941389
Recruiting
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Location: Birmingham AL, Atlanta GA, Memphis TN, St Louis MO,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 18
Code: NCT05504291
Phase 2, Recruiting
Quality of End-of-Life Care for Children With Cancer
for
Childhood Hematopoietic and Lymphatic System Neoplasm,
Location: Birmingham AL, Atlanta GA, Pensacola FL, Augusta GA,
Sponsor: Children's Oncology Group
Sex: All
Age: 18+
Code: NCT07412002
Recruiting
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
for
Recurrent World Health Organization (WHO) Grade II Glioma,
Location: Birmingham AL, Gainesville FL, St Louis MO,
Sponsor: University of California, San Francisco
Sex: All
Age: 1 - 25
Code: NCT04485559
Phase 1, Recruiting
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants
for
Gout
Location: Birmingham AL, Atlanta GA, Shelby NC, Lexington KY,
Sponsor: Crystalys Therapeutics
Sex: All
Age: 18 - 70+
Code: NCT07535034
Phase 2, Recruiting
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia
for
Acute Myeloid Leukemia Post Cytotoxic Therapy,
Location: Birmingham AL, Atlanta GA, Memphis TN, Cincinnati OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 0 - 21
Code: NCT07012044
Phase 1, Recruiting
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
for
Congenital Diaphragmatic Hernia
Location: Birmingham AL, Atlanta GA, Nashville TN, Memphis TN,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0
Code: NCT05213676
Phase 4, Recruiting
Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
for
Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT07197515
Recruiting
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: Birmingham AL, Nashville TN, New Orleans LA,
Sponsor: Children's Oncology Group
Sex: All
Age: 2 - 18
Code: NCT05711667
Phase 3, Recruiting
A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
for
Type 2 Diabetes
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 12 - 18
Code: NCT06902077
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
for
Diffuse Midline Glioma, H3 K27-Altered,
Location: Birmingham AL, Atlanta GA, Memphis TN, St Louis MO,
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
for
MPNST, NF1, Sarcoma
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT05253131
Phase 2, Recruiting
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
for
Atypical Teratoid/Rhabdoid Tumor,
Location: Birmingham AL, Nashville TN, Little Rock AR,
Sponsor: Milton S. Hershey Medical Center
Sex: All
Age: 0 - 26
Code: NCT06465199
Phase 1, Phase 2, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
for
Rhabdomyosarcoma
Location: Birmingham AL, Atlanta GA, Nashville TN, Mobile AL,